
Bioorganic and Medicinal Chemistry Letters p. 1595 - 1600 (1998)
Update date:2022-08-02
Topics:
Lu, Tianbao
Tomczuk, Bruce
Illig, Carl R.
Bone, Roger
Murphy, Larry
Spurlino, John
Salemme, F. Raymond
Soll, Richard M.
We describe the in vitro evaluation and crystallographic analysis of a new class of potent and selective, non-aminoacid-based, small-molecule thrombin inhibitors, exemplified by 14. This class of achiral inhibitors lacks an amide-based backbone, exhibits nM inhibition of thrombin, and is selective for thrombin. Compound 14 does not interact with the active-site catalytic apparatus and is anchored to the enzyme via a single network of hydrogen bonds to Asp 189 of the S1 pocket.
View MoreContact:+86-18653358619
Address:zibo
Guangzhou Reachin Chemical Co., Ltd
Contact:+86-20-37087379 ext.604
Address:A122C-1, Tianyuan Plaza, 401 Tianyuan Rd., Tianhe, Guangzhou, China
Taizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
Suzhou Howsine Biological Technology Co.,Ltd(expird)
website:http://www.howsine.com
Contact:86-512-67262751
Address:No 3,Weihua Road ,Suzhou Industrial Park ,Jiangsu ,China.
Doi:10.1021/ja021177r
(2003)Doi:10.14233/ajchem.2014.16226
(2014)Doi:10.1002/ejoc.201700019
(2017)Doi:10.1246/bcsj.38.1158
(1965)Doi:10.1002/anie.201908052
(2019)Doi:10.1002/anie.200901730
(2009)